(DNOV) FT Cboe Vest U.S. Equity - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • • Defined Outcome
DNOV: Options, ETF, Equity, Index
The FT Cboe Vest U.S. Equity Deep Buffer ETF - November (DNOV) is a defined outcome ETF designed to provide investors with exposure to the S&P 500 while incorporating downside protection. Under normal market conditions, the fund allocates substantially all its assets to FLEX Options, which are exchange-traded, customizable option contracts. These options are tied to the SPDR S&P 500 ETF Trust, allowing the fund to seek returns based on the S&P 500s performance while mitigating potential losses. The ETF is non-diversified, concentrating its investments in these specialized options to achieve its defined outcome strategy.
As of the latest data, DNOV has an average 20-day volume of 9,416 shares, indicating moderate trading activity. The funds last price was 43.32, with a 20-day SMA of 43.59 and a 50-day SMA of 43.36, suggesting a slight bullish trend in the short term. The 200-day SMA of 42.32 indicates longer-term stability. The ATR of 0.26 reflects low volatility, suggesting the funds price movements are relatively stable. With an AUM of $326.61 million, DNOV is a sizeable fund in its category, focusing on delivering specific risk-adjusted returns through its options-based strategy.
Additional Sources for DNOV ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
DNOV ETF Overview
Market Cap in USD | 326m |
Category | Defined Outcome |
TER | 0.85% |
IPO / Inception | 2019-11-15 |
DNOV ETF Ratings
Growth 5y | 74.1% |
Fundamental | - |
Dividend | 0.0% |
Rel. Strength Industry | -4.55 |
Analysts | - |
Fair Price Momentum | 41.03 USD |
Fair Price DCF | - |
DNOV Dividends
No Dividends PaidDNOV Growth Ratios
Growth Correlation 3m | 1.1% |
Growth Correlation 12m | 94.5% |
Growth Correlation 5y | 82.5% |
CAGR 5y | 9.10% |
CAGR/Max DD 5y | 0.95 |
Sharpe Ratio 12m | 1.03 |
Alpha | -1.26 |
Beta | 0.30 |
Volatility | 11.13% |
Current Volume | 10k |
Average Volume 20d | 7.1k |
As of March 13, 2025, the stock is trading at USD 41.85 with a total of 9,996 shares traded.
Over the past week, the price has changed by -2.49%, over one month by -4.15%, over three months by -3.64% and over the past year by +4.55%.
Yes. Based on ValueRay Analyses, FT Cboe Vest U.S. Equity (BATS:DNOV) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 74.06 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DNOV as of March 2025 is 41.03. This means that DNOV is currently overvalued and has a potential downside of -1.96%.
FT Cboe Vest U.S. Equity has no consensus analysts rating.
According to ValueRays Forecast Model, DNOV FT Cboe Vest U.S. Equity will be worth about 44.7 in March 2026. The stock is currently trading at 41.85. This means that the stock has a potential upside of +6.86%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 44.7 | 6.9% |